People · Operator
Named in public records as an officer, director or promoter · active 2023–2026 · Healthtech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spiro Medical Inc. | — | Healthtech | Series B | $39.1M | $156.6M | 2023 |
| NOXX Therapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $1.5M | $1.7M | 2023 |
KURT GEHLSEN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside KURT GEHLSEN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BRIAN MOONEY | 2 | 2 |
| Claudio Nessi | 1 | 5 |
| Xiangyu Ouyang | 1 | 2 |
| Rinda Sama | 1 | 2 |
| Rapha?l Wisniewski | 1 | 1 |
| Ray Cohen | 1 | 1 |
| Chad Andresen | 1 | 1 |
| ROBERT P FINIZIO | 1 | 1 |
| BRIAN P MOONEY | 1 | 1 |
| DAVE P ADAMS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.